CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
接受 B 细胞成熟抗原靶向 CAR-T 细胞治疗的多发性骨髓瘤患者静脉血栓栓塞：系统综述
英文原题：Venous thromboembolism in patients with multiple myeloma treated with B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy: A systematic review.
查看英文原题
Venous thromboembolism in patients with multiple myeloma treated with B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy: A systematic review.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
摘要
这条来源本身就没有摘要（PubMed 未提供），不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。
论文信息
- 作者
- Las Casas PHFDC、Marco-Ayala J、Lefkou EE、Soares TS、Baghdadi MA、Kempaiah P、Fareed J、Vandreden P
- 单位
- INSERM UMR_S_938, Saint-Antoine Research Center (CRSA), Team "Cancer, Vessels, Biology and Therapeutics" (CaVITE), Research Group "Cancer-Angiogenesis-Thrombosis and Hemostasis", Consultation Thrombosis in Oncology (CoThON), University Institute of Cancerology (UIC), Saint Antoine University Hospital, Assistance Publique Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France.France
- 期刊
- British journal of haematology2026 Apr
- 原文标识
- PubMed 41622574 · DOI 10.1111/bjh.70356